ZA814843B - Substituted purimidin-2-ones, the salts thereof, process for their preparation, pharmaceutical compositions containing them and a method therefor - Google Patents

Substituted purimidin-2-ones, the salts thereof, process for their preparation, pharmaceutical compositions containing them and a method therefor

Info

Publication number
ZA814843B
ZA814843B ZA814843A ZA814843A ZA814843B ZA 814843 B ZA814843 B ZA 814843B ZA 814843 A ZA814843 A ZA 814843A ZA 814843 A ZA814843 A ZA 814843A ZA 814843 B ZA814843 B ZA 814843B
Authority
ZA
South Africa
Prior art keywords
salts
group
compounds
substituted
purimidin
Prior art date
Application number
ZA814843A
Inventor
G Phillipps
I Steeples
R Williamson
Bain Borella B Macdonald
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA814843B publication Critical patent/ZA814843B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compounds of the general formula: <IMAGE> I wherein X represents a halogen atom or a trifluoromethyl group; R1 represents a hydrogen atom or a lower alkyl group and Het represents an optionally substituted C-attached 5-7 membered aromatic heterocyclic ring which ring contains one or more heteroatoms selected from O, N and S and optionally carries a fused ring and where an acidic or basic group is present, the salts thereof have been found to possess excellent metaphase arresting ability and are of use in combating abnormal cell proliferation. Thus a knowledge of the cell division cycles of the normal and abnormal cells enables a cytotoxic drug to be administered while the abnormal cells are in a phase susceptible to attack and while the normal cells are in a non-susceptible phase. The compounds of the invention are prepared by alkylation, deprotection of a protected keto group, oxidation or electrophilic halogenation.
ZA814843A 1980-07-15 1981-07-15 Substituted purimidin-2-ones, the salts thereof, process for their preparation, pharmaceutical compositions containing them and a method therefor ZA814843B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8023083 1980-07-15

Publications (1)

Publication Number Publication Date
ZA814843B true ZA814843B (en) 1983-02-23

Family

ID=10514776

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA814843A ZA814843B (en) 1980-07-15 1981-07-15 Substituted purimidin-2-ones, the salts thereof, process for their preparation, pharmaceutical compositions containing them and a method therefor

Country Status (12)

Country Link
US (1) US4650800A (en)
EP (1) EP0044705B1 (en)
JP (1) JPS5740483A (en)
AT (1) ATE10256T1 (en)
AU (1) AU7300281A (en)
CA (1) CA1159830A (en)
DE (1) DE3167186D1 (en)
DK (1) DK315381A (en)
ES (1) ES8300750A1 (en)
NO (1) NO812432L (en)
NZ (1) NZ197715A (en)
ZA (1) ZA814843B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8420610D0 (en) * 1984-08-14 1984-09-19 Glaxo Group Ltd Chemical compounds
JPH0679095B2 (en) * 1986-04-03 1994-10-05 旭硝子株式会社 Plastic optical fiber transmission fiber

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
ES498337A0 (en) * 1980-01-07 1982-06-01 Nyegaard & Co As A PROCEDURE FOR THE PREPARATION OF 5-HALO-PIRIMIDIN-2- ONAS

Also Published As

Publication number Publication date
ATE10256T1 (en) 1984-11-15
US4650800A (en) 1987-03-17
ES503985A0 (en) 1982-11-01
AU7300281A (en) 1982-01-21
DK315381A (en) 1982-01-16
DE3167186D1 (en) 1984-12-20
EP0044705B1 (en) 1984-11-14
NO812432L (en) 1982-01-18
EP0044705A1 (en) 1982-01-27
ES8300750A1 (en) 1982-11-01
NZ197715A (en) 1984-12-14
JPS5740483A (en) 1982-03-06
CA1159830A (en) 1984-01-03

Similar Documents

Publication Publication Date Title
ES8104275A1 (en) Phthalimidine derivatives and pharmaceutical compositions containing them.
ES8203883A1 (en) Imidazole derivatives, their preparation and compositions containing them.
ZA814845B (en) Substituted pyrimidin-2-ones, the salts thereof, process for their preparation, pharmaceutical compositions containing them and a method therefor
SE8102220L (en) USE OF SUBSTITUTED DERIVATIVES OF 4-PHENYL-4-OXO-2-BUTENIC ACID AS A MEDICINE
ZA8164B (en) 5-halo-pyrimid-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
DE3167186D1 (en) Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
PT76614B (en) THIOMETHYLPYRIDINE DERIVATIVES PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS
DE3069173D1 (en) Substituted phenylamino-2-imidazoline-2 derivatives, their acid addition salts, medicaments containing them and process for their preparation
DE3365933D1 (en) Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds
ES485181A1 (en) Imidazo (1,2-a) imidazoles, their acid addition salts, medicaments containing them and process for their preparation.
ES8308565A1 (en) (1,2)-Fused 1,4-benzodiazepine compounds, process for their preparation and medicines containing these compounds.
ES8103047A1 (en) Aminoisoquinoline derivatives
DE3160719D1 (en) Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them